Hydreight and Victory Square Launch $10 Million Health Accelerator to Fuel Nationwide Expansion of Emerging Healthcare Brands on VSDHOne platform
GlobeNewswire
4:30 AM ET Jan-21-2025
VANCOUVER, British Columbia and LAS VEGAS, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (HYDTF.NaE) (“Hydreight” or the “Company”) (TSXV: NURS) (FSE: SO6), a rapidly growing mobile clinical network and medical platform and VSDHOne, its innovative telehealth and e-commerce platform developed in partnership with Victory Square Technologies (VSQTF.NaE) (OTC: VSQTF) (FWB: 6F6), today announced the launch of a D2C Digital Health Accelerator program. This initiative will invest up to $10 million in the form of cash, a comprehensive suite of VSDHOne resources, services and/or company shares to support emerging healthcare brands poised to improve patient care across the United States. This program directly addresses the massive opportunity in the US healthcare system, projected to reach $7.2 trillion by 2031, according to the Centers for Medicare & Medicaid Services (CMS).
What is VSDHOne?
VSDHOne provides a comprehensive telemedicine platform that empowers businesses, including MedSpas, health and wellness entrepreneurs, retailers, and pharmaceutical brands, to create D2C healthcare solutions in days rather than months. The purpose of launching VSDHOne is to make it easy for any existing brick and mortar or individuals to launch a direct to consumer healthcare brand in a few weeks without worrying about compliance, doctor network, telemedicine and ecommerce Technology, Medical direction and oversight, Pharmacy network, and a medical legal framework in all 50 States.
With the marriage of Virtual and at facility healthcare features, companies can expand beyond their current Bricks and Mortar solutions.
Accelerating Growth with Comprehensive Support
The accelerator program is designed to empower businesses offering treatments and therapies directly to patients, including:
Skincare Treatments: Acne and anti-aging solutions
Hair Loss Treatments
Sexual Health: Hormone Replacement Therapy (TRT), peptides, Sermorelin
GLP-1 Weight Management: Treatments for obesity and weight management
Genetic Testing
Birth Control Options
Oral GLP-1 Therapies
NAD+ Nasal Spray: For anti-aging and energy
Longevity-focused solutions
Addressing the Need
Market Data 
Markets 
